- Report
- April 2024
- 160 Pages
Global
From €4966EUR$4,999USD£4,129GBP
- Report
- September 2024
- 150 Pages
Global
From €4818EUR$4,850USD£4,006GBP
- Clinical Trials
- February 2024
- 1378 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- December 2023
- 75 Pages
Global
From €3472EUR$3,495USD£2,887GBP
- Report
- October 2024
- 83 Pages
Global
From €3500EUR$3,774USD£3,012GBP
- Report
- November 2024
- 50 Pages
Global
From €2633EUR$2,650USD£2,189GBP
- Report
- January 2024
- 96 Pages
Europe
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- January 2024
- 97 Pages
Asia Pacific
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- January 2024
- 92 Pages
North America
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- January 2024
- 92 Pages
Middle East, Africa
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- April 2024
- 80 Pages
United States
From €1490EUR$1,500USD£1,239GBP
- Report
- April 2024
- 100 Pages
Africa
From €1987EUR$2,000USD£1,652GBP
- Report
- September 2023
- 110 Pages
Global
From €5911EUR$5,950USD£4,915GBP
- Report
- November 2023
- 150 Pages
Global
From €4818EUR$4,850USD£4,006GBP
- Report
- January 2024
- 82 Pages
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- September 2023
- 182 Pages
Global
From €3164EUR$3,185USD£2,631GBP
€4520EUR$4,550USD£3,758GBP
- Report
- November 2023
- 140 Pages
Global
From €4421EUR$4,450USD£3,676GBP
- Report
- November 2021
- 109 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- November 2023
- 178 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- April 2023
- 116 Pages
Global
From €4719EUR$4,750USD£3,923GBP
The Brain Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat brain cancer. Brain cancer is a type of cancer that affects the cells of the brain and can be caused by a variety of factors, including genetics, environmental exposure, and lifestyle. Brain cancer drugs are used to treat the symptoms of brain cancer, such as headaches, seizures, and nausea, as well as to slow the progression of the disease.
Brain cancer drugs are typically divided into two categories: chemotherapy and targeted therapy. Chemotherapy drugs are used to kill cancer cells, while targeted therapy drugs are designed to target specific cancer cells and stop them from growing. Both types of drugs are used in combination to treat brain cancer.
Some of the major companies in the Brain Cancer Drugs market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. These companies are involved in the development and sale of drugs used to treat brain cancer, as well as in the research and development of new treatments. Show Less Read more